Delhi HC orders Bombay Shaving Company to withdraw disputed Switch4 razor ad

The Delhi High Court directed Bombay Shaving Company to remove its disputed Switch4 razor advertisement after Gillette India filed a trademark and disparagement suit. The court rejected proposed edits and a disclaimer; the matter is due for a further hearing Thursday.

— Source publishedWed, 16 Sept, 2026, 22:17 IST·First seen Wed, 16 Sept, 2026, 22:23 IST·Source Business Standard · Companies

What happened

Delhi High Court directed Bombay Shaving Company to withdraw its disputed Switch4 razor advertisement following Gillette India’s trademark and disparagement

Why this matters

The case underscores the need for rigorous trademark and disparagement diligence in grooming-brand campaigns, partnerships, and acquisition targets with challenger positioning.

What to watch

  • Whether Bombay Shaving Company confirms full compliance before the Thursday hearing.
  • The court's treatment of trademark use, visual cues, and product-comparison claims in the next order.
  • Any settlement, undertaking, apology, damages discussion, or permanent-injunction request.
  • Appearance of revised Switch4 advertising and whether it avoids direct or implied Gillette references.
  • Residual ad placements on third-party publisher, marketplace, influencer, or retailer channels.
  • Gillette's media response, including defensive promotions or messaging reinforcing category leadership.
  • Immediately remove the Switch4 ad from owned social channels, digital video, ecommerce brand stores, and other controllable placements; seek takedowns from agencies and publishers.
  • Audit all active grooming creative, packaging, influencer briefs, and retailer assets for references or implied comparisons that could create follow-on trademark or disparagement exposure.
  • Shift near-term media spending toward non-comparative Switch4 product claims, trial offers, creator testimonials, and retailer conversion campaigns.
  • Prepare substantiation files for performance, price, and quality claims and assess whether a court-compliant revised campaign is commercially worthwhile.
  • Gillette India is likely to monitor compliance, preserve evidence of residual placements, and use the ruling to challenge similar comparative executions if they recur.